Xinling Luo

Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor

Yueshan Li, Liting Zhang, Yifei Wang et al. · Nature Communications · 2022 · 98 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Structural Optimization and Structure–Activity Relationship Studies of 6,6-Dimethyl-4-(phenylamino)-6<i>H</i>-pyrimido[5,4-<i>b</i>][1,4]oxazin-7(8<i>H</i>)-one Derivatives as A New Class of Potent Inhibitors of Pan-Trk and Their Drug-Resistant Mutants

Shulei Pan, Liting Zhang, Xinling Luo et al. · Journal of Medicinal Chemistry · 2022 · 26 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Discovery of 3,4-Dihydrobenzo[<i>f</i>][1,4]oxazepin-5(2<i>H</i>)-one Derivatives as a New Class of Selective TNIK Inhibitors and Evaluation of Their Anti-Colorectal Cancer Effects

Yueshan Li, Liting Zhang, Ruicheng Yang et al. · Journal of Medicinal Chemistry · 2022 · 22 citations · Full text

Medicine, Oncology, Pharmacology +13

Mesenchymal Stem Cells Prevent SLC39A14‐Dependent Hepatocyte Ferroptosis through Exosomal miR‐16‐5p in Liver Graft

Zhizhao Deng, Weiqi Zeng, Yingxin Gao et al. · Advanced Science · 2024 · 21 citations · Full text

Medicine, Molecular Biology, Molecular Medicine +16

Neutrophil Extracellular Traps (NETs) Are Associated with Type 2 Diabetes and Diabetic Foot Ulcer Related Amputation: A Prospective Cohort Study

Irshat Ibrahim, Yilimire Nuermaimaiti, Gulijianaiti Maimaituxun et al. · Diabetes Therapy · 2024 · 17 citations · Full text

Medicine, Pathobiology, Pathology +17